Chemotherapy-induced mucositis development in a murine model of colitis-associated colorectal cancer

References

• Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15(1):79–94.
   PubMed Web of Science ®Google Scholar
• Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35(7):950–954.
   PubMed Web of Science ®Google Scholar
• Seril DN, Liao J, Yang GY, et al. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003;24(3):353–362.
   PubMed Web of Science ®Google Scholar
• Biancone L, Armuzzi A, Scribano ML, et al. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study. Inflamm Bowel Dis. 2019.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• De Robertis M, Massi E, Poeta ML, et al. The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J Carcinog. 2011;10:9.
   PubMedGoogle Scholar
• van Hogezand RA, Eichhorn RF, Choudry A, et al. Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol Suppl. 2002;37(236):48–53.
   Google Scholar
• McQuade RM, Stojanovska V, Bornstein JC, et al. Colorectal cancer chemotherapy: the evolution of treatment and new approaches. Curr Med Chem. 2017;24(15):1537–1557.
   PubMed Web of Science ®Google Scholar
• Grem JL. 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Invest New Drugs. 2000;18(4):299–313.
   PubMed Web of Science ®Google Scholar
• Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–338.
   PubMed Web of Science ®Google Scholar
• Diasio RB, Harris BE. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet. 1989;16(4):215–237.
   PubMed Web of Science ®Google Scholar
• O'Brien ME, Borthwick A, Rigg A, et al. Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients. Br J Cancer. 2006;95(12):1632–1636.
   PubMed Web of Science ®Google Scholar
• Avallone A, Di Gennaro E, Silvestro L, et al. Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed. Expert Opin Drug Saf. 2014;13(1):113–129.
   PubMed Web of Science ®Google Scholar
• Gibson RJ, Keefe DM, Clarke JM, et al. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother Pharmacol. 2002;50(1):53–58.
   PubMed Web of Science ®Google Scholar
• Lalla RV, Peterson DE. Treatment of mucositis, including new medications. Cancer J. 2006;12(5):348–354.
   PubMed Web of Science ®Google Scholar
• Mashtoub S, Tran CD, Howarth GS. Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats. Exp Biol Med. 2013;238(11):1305–1317.
   PubMed Web of Science ®Google Scholar
• Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998;34(1):39–43.
   PubMed Web of Science ®Google Scholar
• Mitchell EP, Schein PS. Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol. 1982;9(1):52–64.
   PubMed Web of Science ®Google Scholar
• Keefe DM. Gastrointestinal mucositis: a new biological model. Support Care Cancer. 2004;12(1):6–9.
   PubMed Web of Science ®Google Scholar
• Vanhoecke B, Bateman E, Mayo B, et al. Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art. Exp Biol Med. 2015;240(6):725–741.
   Web of Science ®Google Scholar
• Howarth GS, Xian CJ, Read LC. Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of chronic inflammatory bowel disease. Growth Factors. 2000;18(2):119–133.
   PubMed Web of Science ®Google Scholar
• Becker C, Fantini MC, Wirtz S, et al. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut. 2005;54(7):950–954.
   PubMed Web of Science ®Google Scholar
• Howarth GS, Francis GL, Cool JC, Xu X, et al. Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J Nutr. 1996;126(10):2519–2530.
   PubMed Web of Science ®Google Scholar
• Abimosleh SM, Tran CD, Howarth GS. Emu oil reduces small intestinal inflammation in the absence of clinical improvement in a rat model of indomethacin-induced enteropathy. Evid Based Complement Alternat Med. 2013;2013:1.
   Web of Science ®Google Scholar
• Chartier LC, Howarth GS, Lawrance IC, et al. Emu oil improves clinical indicators of disease in a mouse model of colitis-associated colorectal cancer. Dig Dis Sci. 2018;63(1):135–145.
   PubMed Web of Science ®Google Scholar
• Mashtoub S, Howarth GS, Trinder D, et al. Emu oil attenuates disease severity and results in fewer large colonic tumours in a mouse model of colitis-associated colorectal cancer. Gastroenterology. 2017;152(5):S737–S.
   Web of Science ®Google Scholar
• Mashtoub S, Safaeian R, Lawrance IC, et al. Emu oil attenuates disease severity in models of colitis and colitis-associated colorectal cancer. J Gastroen Hepatol. 2016;31:125.
   Web of Science ®Google Scholar
• Bajic JE, Eden GL, Lampton LS, et al. Rhubarb extract partially improves mucosal integrity in chemotherapy-induced intestinal mucositis. WJG. 2016;22(37):8322–8333.
   PubMed Web of Science ®Google Scholar
• Mashtoub S, Lampton LS, Eden GL, et al. Emu oil combined with lyprinol reduces small intestinal damage in a rat model of chemotherapy-induced mucositis. Nutr Cancer. 2016;68(7):1171–1180.
   PubMed Web of Science ®Google Scholar
• Sougiannis AT, VanderVeen BN, Enos RT, et al. Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota. Brain Behav Immun. 2019;80:44–55.
   PubMed Web of Science ®Google Scholar
• Yoshimi K, Hashimoto T, Niwa Y, et al. Use of a chemically induced-colon carcinogenesis-prone Apc-mutant rat in a chemotherapeutic bioassay. BMC Cancer. 2012;12(1):448.
   PubMedGoogle Scholar
• Xiao J, Lu Z, Sheng J, et al. 5-fluorouracil attenuates dextran sodium sulfate-induced acute colitis in mice. Mol Med Rep. 2016;13(3):2821–2828.
   PubMed Web of Science ®Google Scholar